Skip to main content
Premium Trial:

Request an Annual Quote

Promega Buys Turner Biosystems

NEW YORK (GenomeWeb News) – Life sciences products company Promega has purchased Turner Biosystems for an undisclosed sum, Promega said today. The two companies already have an established partnership for integrated bioluminescent technologies.

Turner offers microplate single tube reader luminometers, fluorometers, photometers, and multimode instruments for life sciences labs.

"Over the years, innovating with Promega has created productive instrument/reagent systems that scientists highly value. Both companies are eager to optimize this total systems approach for the bench top," Turner President Mike Molkelke said in a statement.

"Scientists value quality integrated systems because it frees them up to focus on the other demands in their lab. This purchase allows us to offer these systems for more applications," Promega CEO Bill Linton added.

Filed under

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.